Clostridium difficile infection in long-term care facilities: A call to action for antimicrobial stewardship

Clinical Infectious Diseases

Volumn 60, Issue , 2015, Pages S72-S76

  Chopra, Teena ^a   Goldstein, Ellie J C ^b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b R M ALDEN RESEARCH LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antibiotic stewardship; C. difficile colonization; C. difficile infection; long term care facilities; probiotics

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INNATE IMMUNITY; LIFE THREAT; LONG TERM CARE; NURSING HOME; PRIORITY JOURNAL; AGED; CLOSTRIDIUM INFECTIONS; DRUG UTILIZATION; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; UNITED STATES;

AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DRUG UTILIZATION; HEALTH FACILITIES; HUMANS; INFECTION CONTROL; LONG-TERM CARE; MIDDLE AGED; NURSING HOMES; PROBIOTICS; SKILLED NURSING FACILITIES; UNITED STATES;

EID: 84928880915     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ053     Document Type: Article

References (51)

1. Laffan AM, Bellantoni MF, Greenough WB III, et al. Burden of Clostridium difficile-associated diarrhea in a long-term care facility. J Am Geriatr Soc 2006; 54: 1068-73.
2. Long-term and post-acute care (LTPAC) health information technology (HIT) collaborative. Available at: http://ltpachealthit.org/content/aboutlong-term-and-post-acute-care. Accessed 13 June 2013.
3. Lew JF, Glass RI, Gangarosa RE, Cohen IP, Bern C, Moe CL. Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly. J Amer Med Assoc 1991; 265: 3280-4.
4. Sims RV, Hauser RJ, Adewale AO, et al. Acute gastroenteritis in three community-based nursing homes. J Gerontol 1995; 50A: M252-6.
5. Halabi W, Carmichael J, Pigazzi A, Stamos M, Mills S, Nguyen V. Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. J Amer Coll Surg 2013; 217: 802-12.
6. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in longterm acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 2006; 27: 920-5.
7. Pawar D, Tsay R, Nelson DS, et al. Burden of Clostridium difficile infection in long-term care facilities in Monroe County, New York. Infect Control Hosp Epidemiol 2012; 33: 1107-12.
8. Gaynes R, Rimland D, Killum E, et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004; 14: 640-5.
9. Birgand G, Blanckaert K, Carbonne A, et al. Investigation of a large outbreak of Clostridium difficile PCR-ribotype 027 infections in northern France, 2006-2007 and associated clusters in 2008-2009. Euro Surveill 2010; 14: 195-7.
10. Simor AE, Yake SL, Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis 1993; 17: 672-8.
11. Simor AE, Bradley SF, Strausbaugh LJ, et al. Clostridium difficile in longterm care facilities for the elderly. Infect Control Hosp Epidemiol 2002; 23: 696-703.
12. Loeb M, Simor AE, Landry L, et al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med 2001; 16: 376-83.
13. Lee YL, Trupp LD, Lee R, Nothvogel S, Farsad N, Ceraio T. Infection surveillance and antibiotic utilization in a community-based skilled nursing facility. Aging Clin Exp Res 1996; 8: 113-22.
14. Mylotte JM. Measuring antibiotic use in a long-term care facility. Am J Infect Control 1996; 24: 174-9.
15. Thomas DR, Bennett RG, Laughon BE, et al. Postantibiotic colonization with Clostridium difficile in nursing home patients. J Am Geriatr Soc 1990; 38: 415-20.
16. Al-Tureihi FIJ, Hassoun A, Wolf-Klein G, et al. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficileassociated disease in nursing home patients. J Am Med Dir Assoc 2005; 6: 105-8.
17. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control 2013; 41: 390-3.
18. Samore MH, DeGirolami PC, Tlucko A, et al. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994; 18: 181-7.
19. Hung YP, Tsai PJ, Hung KH, et al. Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan. PLoS One 2012; 7: e42415.
20. Loo VG, Bourgault A-M, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365: 1693-703.
21. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-10.
22. Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000; 31: 717-22.
23. Morrison RH, Hall NS, Said M, et al. Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis 2011; 53: 860-9.
24. Zilberberg MD, Shorr AF, Micek ST, Doherty JA, Kollef MH. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med 2009; 37: 2583-9.
25. Bassaris HP, Lianou PE, Legakis NJ, et al. Interaction between Clostridium difficile and polymorphonuclear leucocytes from the elderly and post-operative cancer patients: phagocytosis and bactericidal function. Med Microbiol Immunol 1984; 173: 49-55.
26. Nakamura S, Mikawa M, Nakashio S, et al. Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol 1981; 25: 345-51.
27. Bacon AE 3rd, Fekety R. Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea. Diagn Microbiol Infect Dis 1994; 18: 205-9.
28. Walker KJ, Gilliland SS, Vance-Bryan K, et al. Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors. J Am Geriatr Soc 1993; 41: 940-6.
29. Bender BS, Bennett R, Laughon BE, et al. Is Clostridium difficile endemic in chronic-care facilities? Lancet 1986; 2: 11-3.
30. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990; 336: 97-100.
31. Shim JK, Johnson S, Samore MH, et al. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998; 351: 633-6.
32. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342: 390-7.
33. Goldstein EJC, Polanski J, Touzani M, Citron DM. C difficile associated diarrhea (CDAD) in a long-term acute care facility (LTAC). Anaerobe 2009; 15: 241-3.
34. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143: 42-50.
35. Brooks SE, Veal RO, Kramer M, et al. Reduction in the incidence of Clostridium difficile associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992; 13: 98-103.
36. Verity P, Wilcox MH, Fawley W, Parnell P. Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J Hosp Infect 2001; 13: 204-9.
37. Quinn LK, Chen Y, Herwaldt LA. Infection control policies and practices for Iowa long-term care facility residents with Clostridium difficile infection. Infect Control Hosp Epidemiol 2007; 28: 1228-32.
38. Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis 2000; 31: 752-6.
39. Abbett SK, Yokoe DS, Lipsitz SR, et al. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30: 1062-9.
40. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(suppl 1): S81-92.
41. Mayfield JL, Leet T, Miller J, et al. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000; 31: 995-1000.
42. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127: 1289-94.
43. Drekonja DM, Butler M, MacDonald R, et al. Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med 2011; 155: 839-47.
44. Vardakas KZ, Polyzos KA, Patouni K, Rafailidis PI, Samonis G, Falagas ME. Treatment failure and recurrence of Clostrdium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012; 40: 1-8.
45. Cohen SH, Gerding DN, Johnson S, et al. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
46. Gill HS. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Amer J Clin Nutr 2001; 74: 833-9.
47. Maziade PJ, Andriessen JA, Pereira P, et al. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital. Curr Med Res Opin 2013; 29: 1341-7.
48. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. Brit Med J 2007; 335: 80-3.
49. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105: 1636-41.
50. Dellit T, Owens R, McGowan J, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
51. Brakovich B, Bonham E, VanBrackle L. War on the spore: Clostridium difficile disease among patients in a long-term acute care hospital. J Healthc Qual 2013; 35: 15-21.